Search results
Results From The WOW.Com Content Network
An epinephrine autoinjector (or adrenaline autoinjector, also known by the trademark EpiPen) is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
The history of autism spans over a century; [1] autism has been subject to varying treatments, being pathologized or being viewed as a beneficial part of human neurodiversity. [2] The understanding of autism has been shaped by cultural, scientific, and societal factors, and its perception and treatment change over time as scientific ...
For years, people with severe allergies have been prescribed an epinephrine autoinjector in case of emergency situations. But these injectors—which include the popular EpiPen—involve jabbing a ...
There is an epinephrine metered-dose inhaler sold over the counter in the United States to relieve bronchial asthma. [67] [68] It was introduced in 1963 by Armstrong Pharmaceuticals. [69] A common concentration for epinephrine is 2.25% w/v epinephrine in solution, which contains 22.5 mg/mL, while a 1% solution is typically used for aerosolization.
Sally J. Rogers is professor of MIND Institute and department of Psychiatry and Behavioral Sciences at the University of California, Davis. [1] [2] [3] She is a scientist working on early diagnosis and interventions methods for autism and other neurodevelopmental disorders.
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...